IL17F and psoriasis: Secondly, quantification of local and systemic levels of both IL-17 cytokines in patients with psoriasis, psoriatic arthritis, and ankylosing spondylitis revealed a greater abundance of IL-17F relative to IL-17A (>30-fold) (21).